BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 1585838)

  • 1. Derivation of osteoclasts from hematopoietic colony-forming cells in culture.
    Kerby JA; Hattersley G; Collins DA; Chambers TJ
    J Bone Miner Res; 1992 Mar; 7(3):353-62. PubMed ID: 1585838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of interleukin 3 and of granulocyte-macrophage and macrophage colony stimulating factors on osteoclast differentiation from mouse hemopoietic tissue.
    Hattersley G; Chambers TJ
    J Cell Physiol; 1990 Jan; 142(1):201-9. PubMed ID: 2153687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of osteoclast precursors in multilineage hemopoietic colonies.
    Hattersley G; Kerby JA; Chambers TJ
    Endocrinology; 1991 Jan; 128(1):259-62. PubMed ID: 1986920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoclastic potential of human CFU-GM: biphasic effect of GM-CSF.
    Hodge JM; Kirkland MA; Aitken CJ; Waugh CM; Myers DE; Lopez CM; Adams BE; Nicholson GC
    J Bone Miner Res; 2004 Feb; 19(2):190-9. PubMed ID: 14969388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of macrophage colony stimulating factor and granulocyte-macrophage colony stimulating factor on osteoclastic differentiation of hematopoietic progenitor cells.
    Liggett W; Shevde N; Anklesaria P; Sohoni S; Greenberger J; Glowacki J
    Stem Cells; 1993 Sep; 11(5):398-411. PubMed ID: 8241951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of colony-stimulating factors in osteoclast development.
    Takahashi N; Udagawa N; Akatsu T; Tanaka H; Shionome M; Suda T
    J Bone Miner Res; 1991 Sep; 6(9):977-85. PubMed ID: 1724107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative roles of osteoclast colony-stimulating factor and macrophage colony-stimulating factor in the course of osteoclast development.
    Lee TH; Fevold KL; Muguruma Y; Lottsfeldt JL; Lee MY
    Exp Hematol; 1994 Jan; 22(1):66-73. PubMed ID: 8282061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage lineage phenotypes and osteoclastogenesis--complexity in the control by GM-CSF and TGF-beta.
    Lari R; Fleetwood AJ; Kitchener PD; Cook AD; Pavasovic D; Hertzog PJ; Hamilton JA
    Bone; 2007 Feb; 40(2):323-36. PubMed ID: 17055352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoclast development from hematopoietic stem cells: apparent divergence of the osteoclast lineage prior to macrophage commitment.
    Hayase Y; Muguruma Y; Lee MY
    Exp Hematol; 1997 Jan; 25(1):19-25. PubMed ID: 8989902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine B-cell stimulatory factor-1 (BSF-1)/interleukin-4 (IL-4) is a multilineage colony-stimulating factor that acts directly on primitive hemopoietic progenitors.
    Kishi K; Ihle JN; Urdal DL; Ogawa M
    J Cell Physiol; 1989 Jun; 139(3):463-8. PubMed ID: 2786878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow.
    Reid CD; Stackpoole A; Meager A; Tikerpae J
    J Immunol; 1992 Oct; 149(8):2681-8. PubMed ID: 1383322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
    Cardier JE; Erickson-Miller CL; Murphy MJ
    Stem Cells; 1997; 15(4):286-90. PubMed ID: 9253112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of recombinant murine granulocyte colony-stimulating factor on granulocyte-macrophage and blast colony formation.
    Suda T; Suda J; Kajigaya S; Nagata S; Asano S; Saito M; Miura Y
    Exp Hematol; 1987 Oct; 15(9):958-65. PubMed ID: 3498640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of recombinant human M-CSF, IL-3, GM-CSF and calcitriol in clonal development of osteoclast precursors in primate bone marrow.
    Povolny BT; Lee MY
    Exp Hematol; 1993 Apr; 21(4):532-7. PubMed ID: 7681783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage colony-stimulating factor release and receptor expression in bone cells.
    Weir EC; Horowitz MC; Baron R; Centrella M; Kacinski BM; Insogna KL
    J Bone Miner Res; 1993 Dec; 8(12):1507-18. PubMed ID: 8304053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant murine granulocyte-macrophage (GM) colony-stimulating factor supports formation of GM and multipotential blast cell colonies in culture: comparison with the effects of interleukin-3.
    Koike K; Ogawa M; Ihle JN; Miyake T; Shimizu T; Miyajima A; Yokota T; Arai K
    J Cell Physiol; 1987 Jun; 131(3):458-64. PubMed ID: 3298286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditions that support long-term production of osteoclast progenitors in vitro.
    Lee MY; Fevold KL; Muguruma Y; Lottsfeldt JL
    Stem Cells; 1997; 15(5):340-6. PubMed ID: 9323795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent regulation of 1,25-dihydroxyvitamin D3 on human bone marrow osteoclastogenesis and myelopoiesis.
    Qi DY; Perkins SL; Kling SJ; Russell RG
    J Cell Biochem; 1999 Mar; 72(3):387-95. PubMed ID: 10022520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.